Evidence map›Paper›PMID 42155595›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2026

TLR9-mediated innate immune signaling contributes to acetaminophen-induced injury in the developing lung.

Anastasia Malyshkina, Mack Solar, Natarajan Balasubramaniyan, Lijun Zheng, David J McCulley, Musah Morro, Cadence Seymour, Eniko Sajti, David J Orlicky, Alexander Sosa and 2 more

Abstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Anastasia MalyshkinaSection of Neonatology, Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, United States.ORCID 0009-0005-4043-8730
Mack SolarSection of Neonatology, Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, United States.
Natarajan BalasubramaniyanSection of Neonatology, Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, United States.
Lijun ZhengSection of Neonatology, Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, United States.
David J McCulleyDivision of Neonatology, Department of Pediatrics, University of California, San Diego, California, United States.
Musah MorroSection of Neonatology, Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, United States.
Cadence SeymourDivision of Neonatology, Department of Pediatrics, University of California, San Diego, California, United States.
Eniko SajtiDivision of Neonatology, Department of Pediatrics, University of California, San Diego, California, United States.ORCID 0000-0002-0531-7715
David J OrlickyDepartment of Pathology, University of Colorado Anschutz School of Medicine, Aurora, Colorado, United States.ORCID 0000-0002-0417-1400
Alexander SosaDepartment of Biomedical Engineering, University of Colorado Denver, Anschutz Campus, Aurora, Colorado, United States.
Bradford J SmithDepartment of Biomedical Engineering, University of Colorado Denver, Anschutz Campus, Aurora, Colorado, United States.ORCID 0000-0002-1583-6762
Clyde J WrightSection of Neonatology, Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, United States.ORCID 0000-0002-8449-5631

Funding

Research Supplement to Promote Diversity in Health Related Research: Pulmonary implications ofperinatal acetaminophen exposureR01HD107700 · NICHD · UNIVERSITY OF COLORADO DENVER · PI Clyde Jason Wright · 2022 to 2026
$2.2M
HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) R01HD107700NICHD NIH HHS R01 HD107700
6 · The paper itself

Abstract

Acetaminophen (APAP) exposures during human development are common. Emerging epidemiological and experimental evidence links these exposures to subsequent pulmonary morbidity; however, the underlying mechanisms remain incompletely defined. Cell-type-specific expression of the xenobiotic enzyme CYP2E1 is a critical determinant of susceptibility to APAP toxicity. CYP2E1-mediated formation of the reactive metabolite N-acetyl-p-benzoquinone imine (NAPQI) induces mitochondrial injury, which can trigger sterile inflammation through Toll-like receptor 9 (TLR9)-dependent innate immune signaling. The developing mouse lung is particularly vulnerable to APAP exposure at

Indexed as

AcetaminophenAcute Lung InjuryImmunity, InnateLungSignal TransductionToll-Like Receptor 9AnimalsFemaleMaleMiceMice, Inbred C57BLMice, KnockoutAcetaminophenTlr9 protein, mouseToll-Like Receptor 9acetaminophen/paracetamolCYP2E1lung injurysterile inflammationTLR9

Identifiers

PMID42155595
PMCPMC13273618

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.